Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: publications utilization cost mammography screening among commercially insured women 50 64 years
… assessment bodies. These evaluations often require cost-utility analyses that help to understand whether new treatments are cost-effective. Utility values are required for health states … “To ensure appropriate inputs to populate future cost-utility models, pharmaceutical developers should select …
… to the challenges that ISPE will address in the next few years. At a time when real-world data is gaining visibility among non-pharmacoepidemiologists, I see ISPE promoting sound … Their focus includes such areas as pharmacovigilance, drug utilization research, comparative effectiveness review, and …
… Clinical Assessments: Racing to the Finish Line at What Cost? Joint Clinical Assessments and Joint Scientific …
Measurement Strategies With a deep understanding of the regulatory environment and reimbursement issues pertaining to clinical outcome assessments (COAs), we work with you to develop and support optimal measurement strategies for your products in …
… survival, adverse events, and economic burden in Medicare-insured patients with mantle cell lymphoma receiving …
… the framework eases discussions on the study design among stakeholders. Additionally, it helps avert biases that … pandemic, when some special populations (e.g., pregnant women) were underrepresented in randomized clinical trials …
Thirteenth Annual FDA Sentinel Initiative Public Workshop Share on: Monday, November 8, 2021, 10am - Tuesday, November 9, 2021, 2pm Workshop registration Image Bradley Layton, PhD , Senior Research Epidemiologist at RTI-HS, will be participating as a …
… in a discrete-choice experiment are asked to choose among treatment options with different sets of benefits and …
… IPECAD Cross Comparison Challenge on Cost-Effectiveness Models in Alz Disease and Related … key role in pricing, access, and reimbursement decisions. Cost-effectiveness models for AD treatments face the common … on how treatment effects for new AD treatments are used in cost-effectiveness models. Such analyses are essential to the …
14th Annual Sentinel Initiative Public Workshop Share on: Tuesday, November 15 - Wednesday, November 16, 2022 Event webpage Bradley Layton, PhD, Director, Epidemiology at RTI Health Solutions is giving a presentation at the 14th Annual Sentinel …